Cargando…
Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence
Chalcones are among the leading bioactive flavonoids with a therapeutic potential implicated to an array of bioactivities investigated by a series of preclinical and clinical studies. In this article, different scientific databases were searched to retrieve studies depicting the biological activitie...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849684/ https://www.ncbi.nlm.nih.gov/pubmed/33536909 http://dx.doi.org/10.3389/fphar.2020.592654 |
_version_ | 1783645346901000192 |
---|---|
author | Salehi, Bahare Quispe, Cristina Chamkhi, Imane El Omari, Nasreddine Balahbib, Abdelaali Sharifi-Rad, Javad Bouyahya, Abdelhakim Akram, Muhammad Iqbal, Mehwish Docea, Anca Oana Caruntu, Constantin Leyva-Gómez, Gerardo Dey, Abhijit Martorell, Miquel Calina, Daniela López, Víctor Les, Francisco |
author_facet | Salehi, Bahare Quispe, Cristina Chamkhi, Imane El Omari, Nasreddine Balahbib, Abdelaali Sharifi-Rad, Javad Bouyahya, Abdelhakim Akram, Muhammad Iqbal, Mehwish Docea, Anca Oana Caruntu, Constantin Leyva-Gómez, Gerardo Dey, Abhijit Martorell, Miquel Calina, Daniela López, Víctor Les, Francisco |
author_sort | Salehi, Bahare |
collection | PubMed |
description | Chalcones are among the leading bioactive flavonoids with a therapeutic potential implicated to an array of bioactivities investigated by a series of preclinical and clinical studies. In this article, different scientific databases were searched to retrieve studies depicting the biological activities of chalcones and their derivatives. This review comprehensively describes preclinical studies on chalcones and their derivatives describing their immense significance as antidiabetic, anticancer, anti-inflammatory, antimicrobial, antioxidant, antiparasitic, psychoactive, and neuroprotective agents. Besides, clinical trials revealed their use in the treatment of chronic venous insufficiency, skin conditions, and cancer. Bioavailability studies on chalcones and derivatives indicate possible hindrance and improvement in relation to its nutraceutical and pharmaceutical applications. Multifaceted and complex underlying mechanisms of chalcone actions demonstrated their ability to modulate a number of cancer cell lines, to inhibit a number of pathological microorganisms and parasites, and to control a number of signaling molecules and cascades related to disease modification. Clinical studies on chalcones revealed general absence of adverse effects besides reducing the clinical signs and symptoms with decent bioavailability. Further studies are needed to elucidate their structure activity, toxicity concerns, cellular basis of mode of action, and interactions with other molecules. |
format | Online Article Text |
id | pubmed-7849684 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78496842021-02-02 Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence Salehi, Bahare Quispe, Cristina Chamkhi, Imane El Omari, Nasreddine Balahbib, Abdelaali Sharifi-Rad, Javad Bouyahya, Abdelhakim Akram, Muhammad Iqbal, Mehwish Docea, Anca Oana Caruntu, Constantin Leyva-Gómez, Gerardo Dey, Abhijit Martorell, Miquel Calina, Daniela López, Víctor Les, Francisco Front Pharmacol Pharmacology Chalcones are among the leading bioactive flavonoids with a therapeutic potential implicated to an array of bioactivities investigated by a series of preclinical and clinical studies. In this article, different scientific databases were searched to retrieve studies depicting the biological activities of chalcones and their derivatives. This review comprehensively describes preclinical studies on chalcones and their derivatives describing their immense significance as antidiabetic, anticancer, anti-inflammatory, antimicrobial, antioxidant, antiparasitic, psychoactive, and neuroprotective agents. Besides, clinical trials revealed their use in the treatment of chronic venous insufficiency, skin conditions, and cancer. Bioavailability studies on chalcones and derivatives indicate possible hindrance and improvement in relation to its nutraceutical and pharmaceutical applications. Multifaceted and complex underlying mechanisms of chalcone actions demonstrated their ability to modulate a number of cancer cell lines, to inhibit a number of pathological microorganisms and parasites, and to control a number of signaling molecules and cascades related to disease modification. Clinical studies on chalcones revealed general absence of adverse effects besides reducing the clinical signs and symptoms with decent bioavailability. Further studies are needed to elucidate their structure activity, toxicity concerns, cellular basis of mode of action, and interactions with other molecules. Frontiers Media S.A. 2021-01-18 /pmc/articles/PMC7849684/ /pubmed/33536909 http://dx.doi.org/10.3389/fphar.2020.592654 Text en Copyright © 2021 Salehi, Quispe, Chamkhi, El Omari, Balahbib, Sharifi-Rad, Bouyahya, Akram, Iqbal, Docea, Caruntu, Leyva-Gómez, Dey, Martorell, Calina, López and Les. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Salehi, Bahare Quispe, Cristina Chamkhi, Imane El Omari, Nasreddine Balahbib, Abdelaali Sharifi-Rad, Javad Bouyahya, Abdelhakim Akram, Muhammad Iqbal, Mehwish Docea, Anca Oana Caruntu, Constantin Leyva-Gómez, Gerardo Dey, Abhijit Martorell, Miquel Calina, Daniela López, Víctor Les, Francisco Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence |
title | Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence |
title_full | Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence |
title_fullStr | Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence |
title_full_unstemmed | Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence |
title_short | Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence |
title_sort | pharmacological properties of chalcones: a review of preclinical including molecular mechanisms and clinical evidence |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849684/ https://www.ncbi.nlm.nih.gov/pubmed/33536909 http://dx.doi.org/10.3389/fphar.2020.592654 |
work_keys_str_mv | AT salehibahare pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence AT quispecristina pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence AT chamkhiimane pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence AT elomarinasreddine pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence AT balahbibabdelaali pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence AT sharifiradjavad pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence AT bouyahyaabdelhakim pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence AT akrammuhammad pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence AT iqbalmehwish pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence AT doceaancaoana pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence AT caruntuconstantin pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence AT leyvagomezgerardo pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence AT deyabhijit pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence AT martorellmiquel pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence AT calinadaniela pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence AT lopezvictor pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence AT lesfrancisco pharmacologicalpropertiesofchalconesareviewofpreclinicalincludingmolecularmechanismsandclinicalevidence |